Company Quick10K Filing
Scientific Industries
10-Q 2020-03-31 Filed 2020-05-15
10-Q 2019-12-31 Filed 2020-02-13
10-Q 2019-09-30 Filed 2019-11-14
10-K 2019-06-30 Filed 2019-10-04
10-Q 2019-03-31 Filed 2019-05-14
10-Q 2018-12-31 Filed 2019-02-12
10-Q 2018-09-30 Filed 2018-11-13
10-K 2018-06-30 Filed 2018-09-28
10-Q 2018-03-31 Filed 2018-05-15
10-Q 2017-12-31 Filed 2018-02-14
10-Q 2017-09-30 Filed 2017-11-14
10-K 2017-06-30 Filed 2017-09-28
10-Q 2017-03-31 Filed 2017-05-12
10-Q 2016-12-31 Filed 2017-02-10
10-Q 2016-09-30 Filed 2016-11-14
10-K 2016-06-30 Filed 2016-10-11
10-Q 2016-03-31 Filed 2016-05-12
10-Q 2015-12-31 Filed 2016-02-12
10-Q 2015-09-30 Filed 2015-11-12
10-K 2015-06-30 Filed 2015-09-28
10-Q 2015-03-31 Filed 2015-05-14
10-Q 2014-12-31 Filed 2015-02-13
10-Q 2014-09-30 Filed 2014-11-13
10-K 2014-06-30 Filed 2014-09-26
10-Q 2014-03-31 Filed 2014-05-15
10-Q 2013-12-31 Filed 2014-02-13
10-Q 2013-09-30 Filed 2013-11-14
10-K 2013-06-30 Filed 2013-09-27
10-Q 2013-03-31 Filed 2013-05-14
10-Q 2012-12-31 Filed 2013-02-14
10-Q 2012-09-30 Filed 2012-11-14
10-K 2012-06-30 Filed 2012-09-27
10-Q 2012-03-31 Filed 2012-05-15
10-Q 2011-12-31 Filed 2012-02-14
10-Q 2011-09-30 Filed 2011-10-27
10-K 2011-06-30 Filed 2011-09-16
10-Q 2011-03-31 Filed 2011-05-13
10-Q 2010-12-31 Filed 2011-02-11
10-Q 2010-09-30 Filed 2010-11-12
10-K 2010-06-30 Filed 2010-09-27
10-Q 2010-03-31 Filed 2010-05-14
10-Q 2009-12-31 Filed 2010-02-12
8-K 2020-08-10 Amend Bylaw, Exhibits
8-K 2020-07-17 Enter Agreement, Officers, Exhibits
8-K 2020-06-22
8-K 2020-06-18
8-K 2020-04-14
8-K 2020-02-14
8-K 2020-01-29
8-K 2019-12-07
8-K 2019-03-06
8-K 2019-01-23
8-K 2018-09-27
8-K 2018-02-16

Scientific Industries Financials

SCND Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
RXI Pharmaceuticals (RXII) 7,253 0% -0.5 -194% 3,809 2,059 138 0 -7,398 -7,315 3,963
Ethema Health (GRST) 7,193 0% -1.2 -32% 23,469 33,429 599 0 -7,507 -6,127 7,192
Vivos (RDGL) 7,143 0% -7.6 -561% 197 1,390 8 0 -1,106 -971 7,400
Mikros Systems (MKRS) 7,118 61% -32.0 -4% 3,336 1,082 4,891 3,003 -132 -164 5,234
Pressure Biosciences (PBIO) 7,038 41% -1.9 -331% 2,411 12,035 1,530 630 -7,979 -3,691 6,902
MGT Capital Investments (MGTI) 7,028 -31% -0.6 -144% 5,265 1,955 190 -58 -7,582 -7,576 4,915
International Stem Cell (ISCO) 7,018 62% -5.0 -19% 8,260 4,636 6,635 4,138 -1,551 -1,322 6,555
Star Gold (SRGZ) 6,966 -29.3 -31% 751 35 0 0 -235 -235 6,865
Westmoreland Coal (WLB) 6,952 22% -73.7 -15% 1,467,857 2,190,755 1,264,675 282,069 -219,134 -13,208 973,082
Vaso (VASO) 6,906 54% -5.8 -7% 45,928 43,364 51,794 28,138 -3,037 -964 5,563
Scientific Industries (SCND) 6,822 43% 6.9 5% 8,863 2,553 10,165 4,402 447 801 5,562
Vitality Biopharma (VBIO) 6,792 0% -0.2 -324% 4,197 1,644 95 0 -13,584 -13,577 2,833
Avant Diagnostics (AVDX) 6,739 -3.1 -52% 4,907 3,030 0 0 -2,557 -2,262 6,910
Video Display (VIDE) 6,701 25% -52.2 -3% 9,802 5,465 13,711 3,469 -313 -119 6,215
Boston Therapeutics (BTHE) 6,668 0% -4.7 -207% 743 6,362 13 0 -1,537 -1,423 6,659
China Xuefeng Environmental (CXEE) 6,652 59% -1.6 6% 87,699 19,594 14,414 8,439 5,217 9,810 -16,127
Textmunication Holdings (TXHD) 6,569 61% -2.2 -559% 541 566 758 460 -3,023 -3,023 6,668
IIoT-OXYS (ITOX) 6,490 70% -4.6 -341% 491 2,218 114 80 -1,676 -1,552 7,096
ETF Managers Group Commodity Trust I (RISE) 6,472 6.4 12% 8,210 25 0 0 1,009 1,009 6,472
Global Digital Solutions (GDSI) 6,377 -2.2 -2,467% 83 5,129 0 0 -2,045 -2,866 6,326

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash7837645527697496709469277331,1093434943882443544825306671,0811,2459668971,2111,0259437016791,0531,5071,3581,3541,6021,260
Accounts Receivable8536605696246399437328168169271,1357577957318301,0827378707171,2321,1521,6681,3281,4249721,4751,4071,7221,1901,2162,0001,9741,868
Inventory1,5931,9552,1321,6141,7481,8352,2451,7061,7831,8712,2492,3092,2832,4162,6212,2142,3443,2623,6752,4122,6012,1252,2061,9612,3272,3932,7022,2682,3012,7242,6712,5922,713
PP&E2111991879931821741621,0271491492721,1952502612441,1502232062221,2282332202131,2442152362231,3061861782811,494314
Assets5,0336,1926,0215,7725,8666,0606,4746,1536,0496,3037,4137,1126,9446,7807,0127,1416,9657,9798,5987,5497,4417,2457,1986,8286,7276,9707,3587,3267,3097,5598,5318,2768,863
Accounts Payable107241152115179142140157162151235374342422325228201372422342320300343139377379394428363571451569457
Long-Term Debt14312410586664627700012119864210
Liabilities4331,2351,0607399229711,2307567588621,5891,4331,4021,3791,5801,3911,2782,1982,8411,6171,5561,3671,2371,0001,1231,4311,8561,6231,5271,6522,5111,9352,553
Stockholders' Equity4,6004,9574,9615,0334,9445,0895,2445,3975,2915,4415,8245,6795,5425,4015,4315,7505,6875,7815,7575,9325,8855,8785,9615,8285,6045,5395,5025,7025,7825,9076,0206,3416,309
Income Statement ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue1,5411,1981,5201,9451,3521,8771,6262,2801,4361,7481,7861,8231,6621,6911,7292,7661,4442,0281,6744,4511,5592,6841,9111,9961,2811,8922,0992,0392,1633,0542,9442,004
Cost of Revenue9377079201,2808871,0478111,4318429301,0891,3181,1621,0829621,6018491,1909932,6478901,8891,0551,4378291,1271,3311,0931,1881,9721,5801,024
Gross Profit6044905996644648308158495948186975055006097671,1655958386811,8036707958565594527667681,2369469761,0811,364980
R&D4779125125120135101949791114125107116947485849386115105114103129133118141117109121183237
SG&A4804954904804365015095555005596605956227736367335756236231,290629633659633629622734720653710774923819
Tax2520-0056603310048-20-604-4413781829-1154186201701597003630100-4141
Net Income59-55-870-621381501702135-60-153-161-13819289-6094-37168-494566-135-233-81-3819114211894292-56
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-66253-10625120-21330235-159206-227215-260-148213342-44-123-481,095-152-299655-159104-237-1640746187675-324
Cash Investing-59-270-10-11-222-10-224-16241-5496554-3947-313-6-10-38250-8-19-12-2-42-43-49-5-140-65-26
Cash Financing-94-23-45-309-12910043-1509899270500-1,181-119248-329-25-14438-2-42-248-3627